Antisoma's preliminary results for the year ended 30 June 2010 - MarketWatch (press release)

Antisoma's preliminary results for the year ended 30 June 2010 MarketWatch (press release) Positive results have already been achieved in animal models of inflammatory bowel disease and rheumatoid arthritis, and we are now working towards ... and more »

Rare Blood Vessel Disease Could Have New Treatment Option - BusinessWeek

Rare Blood Vessel Disease Could Have New Treatment Option BusinessWeek WEDNESDAY, July 14 (HealthDay News) -- A drug already used to treat lymphoma and rheumatoid arthritis shows promise as an option to treat ... Researchers find new therapy for vasculitisLos Angeles Times all 31 news articles »

European Commission Approves ORENCIA in Combination with Methotrexate for ... - MarketWatch (press release)

European Commission Approves ORENCIA in Combination with Methotrexate for ... MarketWatch (press release) +The Disease Activity Score (DAS) is a combined index that was developed to measure disease activity in patients with Rheumatoid Arthritis (RA). ... and more »

New Guidance for Methotrexate in RA - MedPage Today

New Guidance for Methotrexate in RA MedPage Today New Canadian recommendations on the use of methotrexate in rheumatoid arthritis focus on routine clinical practice concerns -- ranging from drug ...